AAAAAA

   
Results: 1-24 |
Results: 24
HEALTH AND EFFICIENCY - CLINICAL EFFECTIVENESS DISSECTED
Authors: KEANEY M LORIMER AR
Citation: M. Keaney et Ar. Lorimer, HEALTH AND EFFICIENCY - CLINICAL EFFECTIVENESS DISSECTED, Health care analysis, 6(3), 1998, pp. 208-215
DIFFERENCES BETWEEN AMLODIPINE AND LISINOPRIL IN CONTROL OF CLINIC AND 24 HOUR AMBULATORY BLOOD PRESSURES
Authors: LORIMER AR LYONS D FOWLER G PETRIE JC ROTHMAN MT
Citation: Ar. Lorimer et al., DIFFERENCES BETWEEN AMLODIPINE AND LISINOPRIL IN CONTROL OF CLINIC AND 24 HOUR AMBULATORY BLOOD PRESSURES, Journal of human hypertension, 12(6), 1998, pp. 411-416
INFLUENCE OF PRAVASTATIN AND PLASMA-LIPIDS ON CLINICAL EVENTS IN THE WEST OF SCOTLAND CORONARY PREVENTION STUDY (WOSCOPS)
Authors: PACKARD CJ SHEPHERD J COBBE SM FORD I ISLES CG MCKILLOP JH MACFARLANE PW LORIMER AR NORRIE J
Citation: Cj. Packard et al., INFLUENCE OF PRAVASTATIN AND PLASMA-LIPIDS ON CLINICAL EVENTS IN THE WEST OF SCOTLAND CORONARY PREVENTION STUDY (WOSCOPS), Circulation, 97(15), 1998, pp. 1440-1445
COMPLIANCE AND ADVERSE EVENT WITHDRAWAL - THEIR IMPACT ON THE WEST OFSCOTLAND CORONARY PREVENTION STUDY
Authors: SHEPHERD J COBBE SM LORIMER AR MCKILLOP JH FORD I PACKARD CJ MACFARLANE PW ISLES C OLIVER MF LEVER AF BROWN BW LEDINGHAM JGG POCOCK SJ RIFKIND BM VALLANCE BD LORIMER AR BALLANTYNE D ANDERSON L DUNCAN D KEAN S LAWRENCE A MCGRATH J MONTGOMERY V NORRIE J PERCY M POMPHREY E WHITEHOUSE A CAMERON P PARKER P PORTEOUS F FLETCHER L KILDAY C SHOAT D LATIF S KENNEDY J BELL M BIRRELL R MELLIES M MAYERS J CAMPBELL W
Citation: J. Shepherd et al., COMPLIANCE AND ADVERSE EVENT WITHDRAWAL - THEIR IMPACT ON THE WEST OFSCOTLAND CORONARY PREVENTION STUDY, European heart journal, 18(11), 1997, pp. 1718-1724
BASE-LINE RISK-FACTORS AND THEIR ASSOCIATION WITH OUTCOME IN THE WESTOF SCOTLAND CORONARY PREVENTION STUDY
Authors: SHEPHERD J COBBE SM LORIMER AR MCKILLOP JH FORD I PACKARD CJ MACFARLANE PW ISLES C OLIVER MF LEVER AF BROWN BW LEDINGHAM JGG POCOCK SJ RIFKIND BM VALLANCE BD MCKILLIP JH BALLANTYNE D NORRIE J ANDERSON L DUNCAN D KEAN S LAWRENCE A MCGRATH J MONTGOMERY V PERCY M POMPHREY E WHITEHOUSE A CAMERON P PARKER P PORTEOUS F FLETCHER L KILDAY C SHOAT D LATIF S KENNEDY J BELL MA BIRRELL R MELLIES M MEYER J CAMPBELL W
Citation: J. Shepherd et al., BASE-LINE RISK-FACTORS AND THEIR ASSOCIATION WITH OUTCOME IN THE WESTOF SCOTLAND CORONARY PREVENTION STUDY, The American journal of cardiology, 79(6), 1997, pp. 756-762
IMPAIRED HEART-RATE-VARIABILITY PREDICTS INCREASES MORTALITY IN HYPERTENSIVE LEFT-VENTRICULAR HYPERTROPHY
Authors: WALLBRIDGE DR MCLAUGHLIN SC COBBE SM MACFARLANE PW LORIMER AR DUNN FG PRINGLE SD
Citation: Dr. Wallbridge et al., IMPAIRED HEART-RATE-VARIABILITY PREDICTS INCREASES MORTALITY IN HYPERTENSIVE LEFT-VENTRICULAR HYPERTROPHY, HEART, 75(5), 1996, pp. 141-141
EFFECTS OF COLESTIPOL ALONE AND IN COMBINATION WITH SIMVASTATIN ON APOLIPOPROTEIN-B METABOLISM
Authors: GAW A PACKARD CJ LINDSAY GM MURRAY EF GRIFFIN BA CASLAKE MJ COLQUHOUN I WHEATLEY DJ LORIMER AR SHEPHERD J
Citation: A. Gaw et al., EFFECTS OF COLESTIPOL ALONE AND IN COMBINATION WITH SIMVASTATIN ON APOLIPOPROTEIN-B METABOLISM, Arteriosclerosis, thrombosis, and vascular biology, 16(2), 1996, pp. 236-249
WEST OF SCOTLAND CORONARY PREVENTION STUDY - IDENTIFICATION OF HIGH-RISK GROUPS AND COMPARISON WITH OTHER CARDIOVASCULAR INTERVENTION TRIALS
Authors: SHEPHERD J COBBE SM LORIMER AR MCKILLOP JH FORD I PACKARD CJ MACFARLANE PW ISLES C OLIVER MF LEVER AF BROWN BW LEDINGHAM JGG POCOCK SJ RIFKIND BM VALLANCE BD BALLANTYNE D ANDERSON L DUNCAN D KEAN S LAWRENCE A MCGRATH J MONTGOMERY V NORRIE J PERCY M POMPHREY E WHITEHOUSE A CAMERON P PARKER P PORTEOUS F FLETCHER L KILDAY C SHOAT D LATIF S KENNEDY J BELL MA BIRRELL R MELLIES M MEYER J CAMPBELL W
Citation: J. Shepherd et al., WEST OF SCOTLAND CORONARY PREVENTION STUDY - IDENTIFICATION OF HIGH-RISK GROUPS AND COMPARISON WITH OTHER CARDIOVASCULAR INTERVENTION TRIALS, Lancet, 348(9038), 1996, pp. 1339-1342
INFLUENCE OF BASE-LINE VARIABLES ON THE EFFECT OF PRAVASTATIN THERAPYIN THE WEST OF SCOTLAND CORONARY PREVENTION STUDY
Authors: FORD I COBBE SM ISLES CG LORIMER AR MACFARLANE PW MCKILLOP JH PACKARD CJ SHEPHERD J
Citation: I. Ford et al., INFLUENCE OF BASE-LINE VARIABLES ON THE EFFECT OF PRAVASTATIN THERAPYIN THE WEST OF SCOTLAND CORONARY PREVENTION STUDY, Circulation, 94(8), 1996, pp. 4320-4320
PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Authors: SHEPHERD J COBBE SM FORD I ISLES CG LORIMER AR MACFARLANE PW MCKILLOP JH PACKARD CJ
Citation: J. Shepherd et al., PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA, The New England journal of medicine, 333(20), 1995, pp. 1301-1307
OVERPRODUCTION OF SMALL VERY-LOW-DENSITY LIPOPROTEINS (S-F-20-60) IN MODERATE HYPERCHOLESTEROLEMIA - RELATIONSHIPS BETWEEN APOLIPOPROTEIN-BKINETICS AND PLASMA-LIPOPROTEINS
Authors: GAW A PACKARD CJ LINDSAY GM GRIFFIN BA CASLAKE MJ LORIMER AR SHEPHERD J
Citation: A. Gaw et al., OVERPRODUCTION OF SMALL VERY-LOW-DENSITY LIPOPROTEINS (S-F-20-60) IN MODERATE HYPERCHOLESTEROLEMIA - RELATIONSHIPS BETWEEN APOLIPOPROTEIN-BKINETICS AND PLASMA-LIPOPROTEINS, Journal of lipid research, 36(1), 1995, pp. 158-171
HEART-RATE-VARIABILITY IN LEFT-VENTRICULAR HYPERTROPHY
Authors: MANDAWAT MK WALLBRIDGE DR PRINGLE SD RIYAMI AAS LATIF S MACFARLANE PW LORIMER AR COBBE SM
Citation: Mk. Mandawat et al., HEART-RATE-VARIABILITY IN LEFT-VENTRICULAR HYPERTROPHY, British Heart Journal, 73(2), 1995, pp. 139-144
SCREENING EXPERIENCE AND BASE-LINE CHARACTERISTICS IN THE WEST OF SCOTLAND CORONARY PREVENTION STUDY
Authors: SHEPHERD J COBBE SM LORIMER AR MCKILLOP J FORD I PACKARD C MACFARLANE P ISLES C OLIVER M LEVER AF BROWN BW LEDINGHAM JGG POCOCK S RIFKIND B VALLANCE B BALLANTYNE D ANDERSON L DUNCAN D MONTGOMERY V NORRIE J
Citation: J. Shepherd et al., SCREENING EXPERIENCE AND BASE-LINE CHARACTERISTICS IN THE WEST OF SCOTLAND CORONARY PREVENTION STUDY, The American journal of cardiology, 76(7), 1995, pp. 485-491
DOUBLE-BLIND COMPARISON OF AMLODIPINE AND NIFEDIPINE-RETARD IN THE TREATMENT OF MILD-TO-MODERATE HYPERTENSION
Authors: LORIMER AR ANDERSON JA LAHER MS DAVIES J LAZARUS JH TAYLOR SH SANGHERA S
Citation: Ar. Lorimer et al., DOUBLE-BLIND COMPARISON OF AMLODIPINE AND NIFEDIPINE-RETARD IN THE TREATMENT OF MILD-TO-MODERATE HYPERTENSION, Journal of human hypertension, 8(1), 1994, pp. 65-68
ASSOCIATION BETWEEN MYOTONIC-DYSTROPHY AND PRIMARY HYPERPARATHYROIDISM
Authors: BELL E LORIMER AR HINNIE J
Citation: E. Bell et al., ASSOCIATION BETWEEN MYOTONIC-DYSTROPHY AND PRIMARY HYPERPARATHYROIDISM, Journal of international medical research, 22(5), 1994, pp. 296-298
THE ROLE OF NUCLEAR CARDIOLOGY IN HYPERTENSION
Authors: PRINGLE SD DUNN FG LORIMER AR MCKILLOP JH
Citation: Sd. Pringle et al., THE ROLE OF NUCLEAR CARDIOLOGY IN HYPERTENSION, Nuclear medicine communications, 15(1), 1994, pp. 4-8
IMPAIRED HEART-RATE-VARIABILITY AND INCREASED VENTRICULAR ECTOPIC ACTIVITY IN PATIENTS WITH LEFT-VENTRICULAR HYPERTROPHY
Authors: MANDAWAT MK WALLBRIDGE DR PRINGLE SD RIYAMI AAS LATIF S MACFARLANE PW LORIMER AR COBBE SM
Citation: Mk. Mandawat et al., IMPAIRED HEART-RATE-VARIABILITY AND INCREASED VENTRICULAR ECTOPIC ACTIVITY IN PATIENTS WITH LEFT-VENTRICULAR HYPERTROPHY, Journal of electrocardiology, 27, 1994, pp. 179-181
PREDICTORS OF DEATH IN HYPERTENSIVE LEFT-VENTRICULAR HYPERTROPHY
Authors: WALLBRIDGE DR PRINGLE SD MANDAWAT MK MACFARLANE PW LORIMER AR MCKILLOP JH DUNN FG COBBE SM
Citation: Dr. Wallbridge et al., PREDICTORS OF DEATH IN HYPERTENSIVE LEFT-VENTRICULAR HYPERTROPHY, Circulation, 90(4), 1994, pp. 27-27
PREDICTORS OF DEATH IN HYPERTENSIVE LEFT-VENTRICULAR HYPERTROPHY
Authors: WALLBRIDGE DR PRINGLE SD MANDAWAT MK MACFARLANE PW LORIMER AR MCKILLOP JH DUNN FG COBBE SM
Citation: Dr. Wallbridge et al., PREDICTORS OF DEATH IN HYPERTENSIVE LEFT-VENTRICULAR HYPERTROPHY, Circulation, 90(4), 1994, pp. 27-27
REDUCTION IN CORONARY HEART-DISEASE - CAUTIOUS OPTIMISM
Authors: LORIMER AR PACKHARD CJ
Citation: Ar. Lorimer et Cj. Packhard, REDUCTION IN CORONARY HEART-DISEASE - CAUTIOUS OPTIMISM, Scottish Medical Journal, 38(6), 1993, pp. 168-168
ISOLATED CHD RISK-FACTORS
Authors: COLE F THISTLETHWAITE J LORIMER AR PACKARD C
Citation: F. Cole et al., ISOLATED CHD RISK-FACTORS, Practitioner, 237(1533), 1993, pp. 886
MANAGEMENT OF HYPERCHOLESTEROLEMIA
Authors: LORIMER AR PACKARD C
Citation: Ar. Lorimer et C. Packard, MANAGEMENT OF HYPERCHOLESTEROLEMIA, Practitioner, 237(1526), 1993, pp. 446-449
IMPAIRED HEART-RATE-VARIABILITY IN LEFT-VENTRICULAR HYPERTROPHY
Authors: MANDAWAT MK WALLBRIDGE DR PRINGLE SD RIYAMI AA LATIF S MACFARLANE PW LORIMER AR COBBE SM
Citation: Mk. Mandawat et al., IMPAIRED HEART-RATE-VARIABILITY IN LEFT-VENTRICULAR HYPERTROPHY, Circulation, 88(4), 1993, pp. 115-115
SIGNIFICANCE OF VENTRICULAR ARRHYTHMIAS IN SYSTEMIC HYPERTENSION WITHLEFT-VENTRICULAR HYPERTROPHY
Authors: PRINGLE SD DUNN FG MACFARLANE PW MCKILLOP JH LORIMER AR COBBE SM
Citation: Sd. Pringle et al., SIGNIFICANCE OF VENTRICULAR ARRHYTHMIAS IN SYSTEMIC HYPERTENSION WITHLEFT-VENTRICULAR HYPERTROPHY, The American journal of cardiology, 69(9), 1992, pp. 913-917
Risultati: 1-24 |